Quick Answer
Enlivex Ltd. reported R&D Expense of $9.20 million for fiscal year 2025.
Enlivex Ltd. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $9.20M | -13.4% |
| 2024 | $10.62M | -44.1% |
| 2023 | $19.01M | +1.7% |
| 2022 | $18.69M | +45.1% |
| 2021 | $12.88M | +111.6% |
| 2020 | $6.09M | +8.6% |
| 2019 | $5.60M | +39.6% |
| 2018 | $4.01M | +137.3% |
| 2017 | $1.69M | -16.7% |
| 2016 | $2.03M | -73.6% |
| 2015 | $7.69M | +73.2% |
| 2014 | $4.44M | +506.7% |
| 2013 | $732.0K | +422.9% |
| 2012 | $140.0K | — |
- Enlivex Ltd. showed a decrease of -13.4% in R&D Expense compared to the prior fiscal year.
- Over the 2012–2025 period, Enlivex Ltd.’s r&d expense has grown by 6474.3% (from $140.0 thousand to $9.20 million).
- The most recent figure is from Enlivex Ltd.’s fiscal year 2025 report (Form 20-F), filed with the SEC on March 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: